Angiotech to retain $10 million after cash distribution to shareholders
VANCOUVER – Angiotech Pharmaceuticals, Inc., a Vancouver-based company that formerly traded on the Toronto Stock Exchange, says it will distribute most of its cash to shareholders and employees. The Vancouver-based company will distribute $6 per common share or restricted share unit, or about $80 million, and retain about $10 million. The company, once a profitable Canadian biotechnology developer, restructured under court protection and currently has no debt.
News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.
Leave a Reply
You must be logged in to post a comment.